re: Ann: Neuren announces cancer xenograft te... "The thing to remember is that the enemy of all small Biotech companies is time and money."
That's another reason why the neu sp should be a lot higher. We have plenty of cash and we spend very little, as third parties are funding our two phase two trials. One can safely predict that the Retts trial will also be funded by others, as there is currently lots of support from cash up entities.
I would suggest that the Perseis cancer work doesn't cost that much atm. Possibly our 'partner' in Maryland will help foot the bill too???
ps. I am excited about Perseis, and I'm pleased we have it. It could become a very valuable product indeed. I just thought it was silly that the sp dropped from 3c to 2.4c as there is 17c of value elsewhere within the company. That's what I was trying to communicate in my "My thought" thread.
cheers
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren announces cancer xenograft testing re
Ann: Neuren announces cancer xenograft testing re, page-50
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.59 |
Change
0.380(2.50%) |
Mkt cap ! $1.992B |
Open | High | Low | Value | Volume |
$15.51 | $15.82 | $15.46 | $11.26M | 722.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 696 | $15.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.67 | 6942 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 64 | 15.570 |
1 | 320 | 15.510 |
1 | 181 | 15.450 |
1 | 530 | 15.300 |
1 | 2500 | 15.250 |
Price($) | Vol. | No. |
---|---|---|
15.670 | 2340 | 1 |
15.800 | 20 | 1 |
15.810 | 316 | 1 |
15.850 | 800 | 1 |
15.900 | 500 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online